Table 1.
Huntington’s disease, tauopathy and control cases
| Cases | Gender | Age (years) | Grade (0–4) | CAGn Repeats | CAGn Repeats |
|---|---|---|---|---|---|
| Huntington’s disease | |||||
| HD1 | M | 71 | 1 | 19 | 46 |
| HD2 | M | 61 | 2 | 17 | 46 |
| HD3 | F | 78 | 2 | 17 | 43 |
| HD4 | M | 57 | 3 | 19 | 47 |
| HD5 | F | 64 | 4 | 19 | 45 |
| HD6 | M | 60 | 1 | 23 | 46 |
| HD7 | M | 71 | 1 | 17 | 44 |
| HD8 | F | 61 | 2 | 19 | 46 |
| HD9 | M | 66 | 3 | 17 | 45 |
| HD10 | M | 77 | 3 | 24 | 43 |
| HD11 | M | 77 | 3 | 19 | 43 |
| HD12 | M | 73 | 3 | 21 | 45 |
| HD13 | M | 68 | 4 | 19 | 45 |
| HD14 | M | 58 | 4 | 20 | 48 |
| HD15 | M | 40 | 4 | 18 | 51 |
| HD16 | F | 26 | 4 | 22 | 70 |
| F:M 4:12 | Average 63 ± 13.80 | ||||
| Sporadic tauopathies | |||||
| AD | F | 78 | 18 | 18 | |
| PSP | M | 75 | 20 | 20 | |
| PiD | F | 68 | 19 | 24 | |
| CBD | M | 79 | 28 | 33 | |
| F:M 2:2 | Average 75 ± 4.97 | ||||
| Controls | |||||
| CTL1 | M | 67 | 0 | 20 | |
| CTL2 | M | 72 | 0 | 21 | |
| CTL3 | M | 69 | 0 | 20 | |
| CTL4 | M | 80 | 0 | 20 | |
| CTL5 | F | 83 | 0 | 19 | |
| F:M 1:4 | Average 74.2 ± 6.98 | ||||
AD = Alzheimer's disease; CBD = corticobasal degeneration; PiD = Pick's disease; PSP = progressive supranuclear palsy.